Inside Out: Targeting NHE1 as an Intracellular and Extracellular Regulator of Cancer Progression

Chemical Biology and Drug Design

Volumn 81, Issue 1, 2013, Pages 85-101

  Provost, Joseph J ^a,b   Wallert, Mark A ^a,b  

^a NORTH DAKOTA STATE UNIVERSITY   (United States)

^b MINNESOTA STATE UNIVERSITY MOORHEAD   (United States)

Author keywords

Gene expression; Kinase; Metastasis; Phosphatase; Protein protein interaction; Signal transduction and modulators (activation inhibiton); Therapeutic target

Indexed keywords

CALCINEURIN; CALCINEURIN B; EZRIN; MITOGEN ACTIVATED PROTEIN KINASE; MOESIN; PHOSPHATIDYLINOSITIDE; RADIXIN; RAF PROTEIN; RAS PROTEIN; SODIUM PROTON EXCHANGE PROTEIN 1; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CANCER THERAPY; GENOME; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PERSONALIZED MEDICINE; PH MEASUREMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

CALCIUM-BINDING PROTEINS; CATION TRANSPORT PROTEINS; DISEASE PROGRESSION; HUMANS; HYDROGEN-ION CONCENTRATION; NEOPLASMS; PROTEIN ISOFORMS; RECEPTORS, GROWTH FACTOR; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION; SODIUM-HYDROGEN ANTIPORTER;

EID: 84871390701     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/cbdd.12035     Document Type: Article

References (161)

1. Gonzalez-Angulo A.M., Hennessy B.T., Mills G.B. (2010) Future of personalized medicine in oncology: a systems biology approach. J Clin Oncol;28:2777-2783.
2. Swanton C., Caldas C. (2010) From genomic landscapes to personalized cancer management-is there a roadmap? Ann N Y Acad Sci;1210:34-44.
3. Chin L., Andersen J.N., Futreal P.A. (2011) Cancer genomics: from discovery science to personalized medicine. Nat Med;17:297-303.
4. Hanahan D., Weinberg R.A. (2011) Hallmarks of cancer: the next generation. Cell;144:646-674.
5. Parks S.K., Chiche J., Pouyssegur J. (2011) pH control mechanisms of tumor survival and growth. J Cell Physiol;226:299-308.
6. Webb B.A., Chimenti M., Jacobson M.P., Barber D.L., et al. (2011) Dysregulated pH: a perfect storm for cancer progression. Nat Rev Cancer;11:671-677.
7. Cardone R.A., Casavola V., Reshkin S.J. (2005) The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis. Nat Rev Cancer;5:786-795.
8. Stock C., Cardone R.A., Busco G., Krahling H., Schwab A., Reshkin S.J. (2008) Protons extruded by NHE1: digestive or glue? Eur J Cell Biol;87:591-599.
9. Martin C., Pedersen S.F., Schwab A., Stock C. (2011) Intracellular pH gradients in migrating cells. Am J Physiol Cell Physiol;300:C490-C495.
10. Stock C., Schwab A. (2009) Protons make tumor cells move like clockwork. Pflugers Arch;458:981-992.
11. Lauritzen G., Stock C.M., Lemaire J., Lund S.F., Jensen M.F., Damsgaard B. et al. (2012) The Na+/H+ exchanger NHE1, but not the Na+, HCO3(-) cotransporter NBCn1, regulates motility of MCF7 breast cancer cells expressing constitutively active ErbB2. Cancer Lett;317:172-183.
12. Thiry A., Dogne J.M., Masereel B., Supuran C.T. (2006) Targeting tumor-associated carbonic anhydrase IX in cancer therapy. Trends Pharmacol Sci;27:566-573.
13. Meima M.E., Mackley J.R., Barber D.L. (2007) Beyond ion translocation: structural functions of the sodium-hydrogen exchanger isoform-1. Curr Opin Nephrol Hypertens;16:365-372.
14. Baumgartner M., Patel H., Barber D.L. (2004) Na(+)/H(+) exchanger NHE1 as plasma membrane scaffold in the assembly of signaling complexes. Am J Physiol Cell Physiol;287:C844-C850.
15. Yang X., Wang D., Dong W., Song Z., Dou K. (2011) Expression and modulation of Na(+)/H(+) exchanger 1 gene in hepatocellular carcinoma: a potential therapeutic target. J Gastroenterol Hepatol;26:364-370.
16. Harguindey S., Arranz J.L., Wahl M.L., Orive G., Reshkin S.J. (2009) Proton transport inhibitors as potentially selective anticancer drugs. Anticancer Res;29:2127-2136.
17. Loo S.Y., Chang M.K., Chua C.S., Kumar A.P., Pervaiz S., Clement M.V. (2012) NHE-1: a promising target for novel anti-cancer therapeutics. Curr Pharm Des;18:1372-1382.
18. Izumi H., Torigoe T., Ishiguchi H., Uramoto H., Yoshida Y., Tanabe M. et al. (2003) Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy. Cancer Treat Rev;29:541-549.
19. Harold F.M., Papineau D. (1972) Cation transport and electrogenesis by Streptococcus faecalis. II. Proton and sodium extrusion. J Membr Biol;8:45-62.
20. Sardet C., Franchi A., Pouyssegur J. (1989) Molecular cloning, primary structure, and expression of the human growth factor-activatable Na+/H+ antiporter. Cell;56:271-280.
21. Orlowski J., Grinstein S. (1997) Na+/H+ exchangers of mammalian cells. J Biol Chem;272:22373-22376.
22. Hisamitsu T., Ben Ammar Y., Nakamura T.Y., Wakabayashi S. (2005) The role of pH dynamics and the Na+/H+ antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin - one single nature. Biochim Biophys Acta;1756:1-24.
23. Stock C., Schwab A. (2006) Role of the Na/H exchanger NHE1 in cell migration. Acta Physiol;187:149-157.
24. Malo M.E., Fliegel L. (2006) Physiological role and regulation of the Na+/H+ exchanger. Can J Physiol Pharmacol;84:1081-1095.
25. Hisamitsu T., Ben Ammar Y., Nakamura T.Y., Wakabayashi S. (2006) Dimerization is crucial for the function of the Na+/H+ exchanger NHE1. Biochemistry;45:13346-13355.
26. Fuster D., Moe O.W., Hilgemann D.W. (2008) Steady-state function of the ubiquitous mammalian Na/H exchanger (NHE1) in relation to dimer coupling models with 2Na/2H stoichiometry. J Gen Physiol;132:465-480.
27. Slepkov E.R., Rainey J.K., Sykes B.D., Fliegel L. (2007) Structural and functional analysis of the Na+/H+ exchanger. Biochem J;401:623-633.
28. Landau M., Herz K., Padan E., Ben-Tal N. et al. (2007) Model structure of the Na+/H+ exchanger 1 (NHE1): functional and clinical implications. J Biol Chem;282:37854-37863.
29. Tzeng J., Lee B.L., Sykes B.D., Fliegel L. (2011) Structural and functional analysis of critical amino acids in TMVI of the NHE1 isoform of the Na+/H+ exchanger. Biochim Biophys Acta;1808:2327-2335.
30. Lee B.L., Sykes B.D., Fliegel L. (2011) Structural analysis of the Na+/H+ exchanger isoform 1 (NHE1) using the divide and conquer approach. Biochem Cell Biol;89:189-199.
31. Boedtkjer E., Bunch L., Pedersen S.F. (2012) Physiology, pharmacology and pathophysiology of the pH regulatory transport proteins NHE1 and NBCn1: similarities, differences, and implications for cancer therapy. Curr Pharm Des;18:1345-1371.
32. Nygaard E.B., Lagerstedt J.O., Bjerre G., Shi B., Budamagunta M., Poulsen K.A. et al. (2011) Structural modeling and electron paramagnetic resonance spectroscopy of the human Na+/H+ exchanger isoform 1, NHE1. J Biol Chem;286:634-648.
33. Stock C., Ludwig F.T., Schwab A. (2012) Is the multifunctional Na(+)/H(+) exchanger isoform 1 a potential therapeutic target in cancer? Curr Med Chem;19:647-660.
34. Ahmad S., Ngu K., Combs D.W., Wu S.C., Weinstein D.S., Liu W., et al. (2004) Aminoimidazoles as bioisosteres of acylguanidines: novel, potent, selective and orally bioavailable inhibitors of the sodium hydrogen exchanger isoform-1. Bioorg Med Chem Lett;14:177-180.
35. Lee S., Lee H., Yi Y.K., Lee B.H., Yoo S., Lee K., et al. (2005) 4-Substituted (benzo[b]thiophene-2-carbonyl)guanidines as novel Na+/H+ exchanger isoform-1 (NHE-1) inhibitorssco. Bioorg Med Chem Lett;15:2998-3001.
36. Marala R.B., Brown J.A., Kong J.X., Tracey W.R., Knight D.R., Wester R.T. et al. (2002) Zoniporide: a potent and highly selective inhibitor of human Na(+)/H(+) exchanger-1. Eur J Pharmacol;451:37-41.
37. Guzman-Perez A., Wester R.T., Allen M.C., Brown J.A., Buchholz A.R., Cook E.R. et al. (2001) Discovery of zoniporide: a potent and selective sodium-hydrogen exchanger type 1 (NHE-1) inhibitor with high aqueous solubility. Bioorg Med Chem Lett;11:803-807.
38. Atwal K.S., O'Neil S.V., Ahmad S., Doweyko L., Kirby M., Dorso C.R. et al. (2006) Synthesis and biological activity of 5-aryl-4-(4-(5-methyl-1H-imidazol-4-yl)piperidin-1-yl)pyrimidine analogs as potent, highly selective, and orally bioavailable NHE-1 inhibitors. Bioorg Med Chem Lett;16:4796-4799.
39. Gebreselassie D., Rajarathnam K., Fliegel L. (1998) Expression, purification, and characterization of the carboxyl-terminal region of the Na+/H+ exchanger. Biochem Cell Biol;76:837-842.
40. Mishima M., Wakabayashi S., Kojima C. (2007) Solution structure of the cytoplasmic region of Na+/H+ exchanger 1 complexed with essential cofactor calcineurin B homologous protein 1. J Biol Chem;282:2741-2751.
41. Norholm A.B., Hendus-Altenburger R., Bjerre G., Kjaergaard M., Pedersen S.F., Kragelund B.B. (2011) The intracellular distal tail of the Na+/H+ exchanger NHE1 is intrinsically disordered: implications for NHE1 trafficking. Biochemistry;50:3469-3480.
42. Neri D., Supuran C.T. (2011) Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discovery;10:767-777.
43. Reshkin S.J., Bellizzi A., Caldeira S., Albarani V., Malanchi I., Poignee M. et al. (2000) Na+/H+ exchanger-dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation-associated phenotypes. FASEB J;14:2185-2197.
44. Putney L.K., Barber D.L. (2003) Na-H exchange-dependent increase in intracellular pH times G2/M entry and transition. J Biol Chem;278:44645-44649.
45. Stuwe L. et al. (2007) pH dependence of melanoma cell migration: protons extruded by NHE1 dominate protons of the bulk solution. J Physiol;585(Pt 2):351-360.
46. Stock C., Mueller M., Kraehling H., Mally S., Noel J., Eder C. et al. (2007) pH nanoenvironment at the surface of single melanoma cells. Cell Physiol Biochem;20:679-686.
47. Provost J.J. et al. (2012) Urokinase plasminogen activator receptor induced non-small cell lung cancer invasion and metastasis requires NHE1 transporter expression and transport activity. Cell Oncol;35:95-110.
48. Taves J. et al. (2008) Sodium hydrogen exchanger and phospholipase D are required for alpha1-adrenergic receptor stimulation of metalloproteinase-9 and cellular invasion in CCL39 fibroblasts. Arch Biochem Biophys;477:60-66.
49. Yang X., Wang D., Dong W., Song Z., Dou K. (2010) Over-expression of Na+/H+ exchanger 1 and its clinicopathologic significance in hepatocellular carcinoma. Med Oncol;27:1109-1113.
50. Bourguignon L.Y. (2008) Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression. Semin Cancer Biol;18:251-259.
51. Bourguignon L.Y., Singleton P.A., Diedrich F., Stern R., Gilad E. (2004) CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion. J Biol Chem;279:26991-27007.
52. Stock C., Gassner B., Hauck C.R., Arnold H., Mally S., Eble J.A. et al. (2005) Migration of human melanoma cells depends on extracellular pH and Na+/H+ exchange. J Physiol;567(Pt 1):225-238.
53. Wu K.L., Khan S., Lakhe-Reddy S., Jarad G., Mukherjee A., Obejero-Paz C.A. et al. (2004) The NHE1 Na+/H+ exchanger recruits ezrin/radixin/moesin proteins to regulate Akt-dependent cell survival. J Biol Chem;279:26280-26286.
54. Slepkov E., Fliegel L. (2004) Regulation of expression of the Na+/H+ exchanger by thyroid hormone. Vitam Horm;69:249-269.
55. Carraro-Lacroix L.R., Ramirez M.A., Zorn T.M., Reboucas N.A., Malnic G. (2006) Increased NHE1 expression is associated with serum deprivation-induced differentiation in immortalized rat proximal tubule cells. Am J Physiol Renal Physiol;291:F129-F139.
56. Paradiso A., Cardone R.A., Bellizzi A., Bagorda A., Guerra L., Tommasino M. et al. (2004) The Na+-H+ exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells. Breast Cancer Res;6:R616-R628.
57. Cardone R.A., Bagorda A., Bellizzi A., Busco G., Guerra L., Paradiso A. et al. (2005) Protein kinase A gating of a pseudopodial-located RhoA/ROCK/p38/NHE1 signal module regulates invasion in breast cancer cell lines. Mol Biol Cell;16:3117-3127.
58. Pang T., Wakabayashi S., Shigekawa M. (2002) Expression of calcineurin B homologous protein 2 protects serum deprivation-induced cell death by serum-independent activation of Na+/H+ exchanger. J Biol Chem;277:43771-43777.
59. Jin Q., Kong B., Yang X., Cui B., Wei Y., Yang Q. (2007) Overexpression of CHP2 enhances tumor cell growth, invasion and metastasis in ovarian cancer. In vivo;21:593-598.
60. Kumar A.P., Chang M.K., Fliegel L., Pervaiz S., Clement M.V. (2007) Oxidative repression of NHE1 gene expression involves iron-mediated caspase activity. Cell Death Differ;14:1733-1746.
61. Akram S., Teong H.F., Fliegel L., Pervaiz S., Clement M.V. (2006) Reactive oxygen species-mediated regulation of the Na+-H+ exchanger 1 gene expression connects intracellular redox status with cells' sensitivity to death triggers. Cell Death Differ;13:628-641.
62. Howells L.M., Berry D.P., Elliott P.J., Jacobson E.W., Hoffmann E., Hegarty B. et al. (2011) Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics, and pharmacodynamics. Cancer Prev Res;4:1419-1425.
63. 2 and caspases 3 and 6 in the absence of cell death. Int J Biochem Cell Biol;41:945-956.
64. Rios E.J., Fallon M., Wang J., Shimoda L.A. (2005) Chronic hypoxia elevates intracellular pH and activates Na+/H+ exchange in pulmonary arterial smooth muscle cells. Am J Physiol Lung Cell Mol Physiol;289:L867-L874.
65. Yang X., Wang D., Dong W., Song Z., Dou K. (2010) Inhibition of Na(+)/H(+) exchanger 1 by 5-(N-ethyl-N-isopropyl) amiloride reduces hypoxia-induced hepatocellular carcinoma invasion and motility. Cancer Lett;295:198-204.
66. Schneider L., Stock C.M., Dieterich P., Jensen B.H., Pedersen L.B., Satir P. et al. (2009) The Na+/H+ exchanger NHE1 is required for directional migration stimulated via PDGFR-alpha in the primary cilium. J Cell Biol;185:163-176.
67. Mo X.G., Chen Q.W., Li X.S., Zheng M.M., Ke D.Z., Deng W. et al. (2011) Suppression of NHE1 by small interfering RNA inhibits HIF-1alpha-induced angiogenesis in vitro via modulation of calpain activity. Microvasc Res;81:160-168.
68. Lucien F., Brochu-Gaudreau K., Arsenault D., Harper K., Dubois C.M. (2011) Hypoxia-induced invadopodia formation involves activation of NHE-1 by the p90 ribosomal S6 kinase (p90RSK). PLoS ONE;6:e28851.
69. Yang X., Wang D., Dong W., Song Z., Dou K. et al. (2011) Suppression of Na+/H+ exchanger 1 by RNA interference or amiloride inhibits human hepatoma cell line SMMC-7721 cell invasion. Med Oncol;28:385-390.
70. Kumar A.P., Quake A.L., Chang M.K., Zhou T., Lim K.S., Singh R. et al. (2009) Repression of NHE1 expression by PPARgamma activation is a potential new approach for specific inhibition of the growth of tumor cells in vitro and in vivo. Cancer Res;69:8636-8644.
71. Chiang Y., Chou C.Y., Hsu K.F., Huang Y.F., Shen M.R. (2008) EGF upregulates Na+/H+ exchanger NHE1 by post-translational regulation that is important for cervical cancer cell invasiveness. J Cell Physiol;214:810-819.
72. Lauritzen G., Jensen M.B., Boedtkjer E., Dybboe R., Aalkjaer C., Nylandsted J. et al. (2010) NBCn1 and NHE1 expression and activity in DeltaNErbB2 receptor-expressing MCF-7 breast cancer cells: contributions to pHi regulation and chemotherapy resistance. Exp Cell Res;316:2538-2553.
73. Putney L.K., Barber D.L. (2004) Expression profile of genes regulated by activity of the Na-H exchanger NHE1. BMC Genomics;5:46.
74. Zhou D., Xue J., Gavrialov O., Haddad G.G. (2004) Na+/H+ exchanger 1 deficiency alters gene expression in mouse brain. Physiol Genomics;18:331-339.
75. Kapus A., Grinstein S., Wasan S., Kandasamy R., Orlowski J. (1994) Functional characterization of three isoforms of the Na+/H+ exchanger stably expressed in Chinese hamster ovary cells. ATP dependence, osmotic sensitivity, and role in cell proliferation. J Biol Chem;269:23544-23552.
76. Orlowski J. (1993) Heterologous expression and functional properties of amiloride high affinity (NHE-1) and low affinity (NHE-3) isoforms of the rat Na/H exchanger. J Biol Chem;268:16369-16377.
77. Tse C.M., Levine S.A., Yun C.H., Montrose M.H., Little P.J., Pouyssegur J. et al. (1993) Cloning and expression of a rabbit cDNA encoding a serum-activated ethylisopropylamiloride-resistant epithelial Na+/H+ exchanger isoform (NHE-2). J Biol Chem;268:11917-11924.
78. Tompa P., Fuxreiter M., Oldfield C.J., Simon I., Dunker A.K., Uversky V.N. (2009) Close encounters of the third kind: disordered domains and the interactions of proteins. BioEssays;31:328-335.
79. Denker S.P., Barber D.L. (2002) Cell migration requires both ion translocation and cytoskeletal anchoring by the Na-H exchanger NHE1. J Cell Biol;159:1087-1096.
80. Denker S.P., Barber D.L. (2002) Ion transport proteins anchor and regulate the cytoskeleton. Curr Opin Cell Biol;14:214-220.
81. Denker S.P., Huang D.C., Orlowski J., Furthmayr H., Barber D.L. (2000) Direct binding of the Na-H exchanger NHE1 to ERM proteins regulates the cortical cytoskeleton and cell shape independently of H(+) translocation. Mol Cell;6:1425-1436.
82. Putney L.K., Denker S.P., Barber D.L. (2002) The changing face of the Na+/H+ exchanger, NHE1: structure, regulation, and cellular actions. Annu Rev Pharmacol Toxicol;42:527-552.
83. Huber V., De Milito A., Harguindey S., Reshkin S.J., Wahl M.L., Rauch C. et al. (2010) Proton dynamics in cancer. J Transl Med;8:57.
84. Chatterjee M., Sequeira L., Jenkins-Kabaila M., Dubyk C.W., Pathak S., van Golen K.L. (2011) Individual rac GTPases mediate aspects of prostate cancer cell and bone marrow endothelial cell interactions. J Signal Transduct;2011:541851.
85. Shiotani S., Sadanaga N., Sugimachi K., Okada S., Tokunaga E., Oki E. et al. (2008) Phosphorylated Rho-kinase (ROCK) as a novel therapeutic target in treatment of breast cancer. J Clin Oncol;26:3508.
86. Liu S., Goldstein R.H., Scepansky E.M., Rosenblatt M. (2009) Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone. Cancer Res;69:8742-8751.
87. Lochhead P.A., Wickman G., Mezna M., Olson M.F. (2010) Activating ROCK1 somatic mutations in human cancer. Oncogene;29:2591-2598.
88. Di Nicolantonio F., Bardelli A. (2006) Kinase mutations in cancer: chinks in the enemy's armour? Curr Opin Oncol;18:69-76.
89. Voyno-Yasenetskaya T., Conklin B.R., Gilbert R.L., Hooley R., Bourne H.R., Barber D.L. (1994) G alpha 13 stimulates Na-H exchange. J Biol Chem;269:4721-4724.
90. Vexler Z.S., Symons M., Barber D.L. (1996) Activation of Na+-H+ exchange is necessary for RhoA-induced stress fiber formation. J Biol Chem;271:22281-22284.
91. Lin X., Voyno-Yasenetskaya T.A., Hooley R., Lin C.Y., Orlowski J., Barber D.L. (1996) Galpha12 differentially regulates Na+-H+ exchanger isoforms. J Biol Chem;271:22604-22610.
92. Hooley R., Yu C.Y., Symons M., Barber D.L. (1996) G alpha 13 stimulates Na+-H+ exchange through distinct Cdc42-dependent and RhoA-dependent pathways. J Biol Chem;271:6152-6158.
93. Wallert M.A., Thronson H.L., Korpi N.L., Olmschenk S.M., McCoy A.C., Funfar M.R. (2005) Two G protein-coupled receptors activate Na+/H+ exchanger isoform 1 in Chinese hamster lung fibroblasts through an ERK-dependent pathway. Cell Signal;17:231-242.
94. Tominaga T., Ishizaki T., Narumiya S., Barber D.L. et al. (1998) p160ROCK mediates RhoA activation of Na-H exchange. EMBO J;17:4712-4722.
95. Sit S.T., Manser E. (2011) Rho GTPases and their role in organizing the actin cytoskeleton. J Cell Sci;124(Pt 5):679-683.
96. Magalhaes M.A., Larson D.R., Mader C.C., Bravo-Cordero J.J., Gil-Henn H., Oser M. et al. (2011) Cortactin phosphorylation regulates cell invasion through a pH-dependent pathway. J Cell Biol;195:903-920.
97. Spencer C., Montalvo J., McLaughlin S.R., Bryan B.A. et al. (2011) Small molecule inhibition of cytoskeletal dynamics in melanoma tumors results in altered transcriptional expression patterns of key genes involved in tumor initiation and progression. Cancer Genomics Proteomics;8:77-85.
98. Persad S., Dedhar S. (2003) The role of integrin-linked kinase (ILK) in cancer progression. Cancer Metastasis Rev;22:375-384.
99. Di Sole F., Vadnagara K., Moe O.W., Babich V. et al. (2011) Calcineurin homologous protein: a multi-functional Ca2+-binding protein family. Am J Physiol Renal Physiol;303:165-179.
100. Ammar Y.B., Takeda S., Hisamitsu T., Mori H., Wakabayashi S. (2006) Crystal structure of CHP2 complexed with NHE1-cytosolic region and an implication for pH regulation. EMBO J;25:2315-2325.
101. Naoe Y., Arita K., Hashimoto H., Kanazawa H., Sato M., Shimizu T. (2005) Structural characterization of calcineurin B homologous protein 1. J Biol Chem;280:32372-32378.
102. Lin X., Barber D.L. (1996) A calcineurin homologous protein inhibits GTPase-stimulated Na-H exchange. Proc Nat Acad Sci USA;93:12631-12636.
103. Matsushita M., Sano Y., Yokoyama S., Takai T., Inoue H., Mitsui K. et al. (2007) Loss of calcineurin homologous protein-1 in chicken B lymphoma DT40 cells destabilizes Na+/H+ exchanger isoform-1 protein. Am J Physiol Cell Physiol;293:C246-C254.
104. Inoue H., Nakamura Y., Nagita M., Takai T., Masuda M., Nakamura N. et al. (2003) Calcineurin homologous protein isoform 2 (CHP2), Na+/H+ exchangers-binding protein, is expressed in intestinal epithelium. Biol Pharm Bull;26:148-155.
105. Pang T., Su X., Wakabayashi S., Shigekawa M. (2001) Calcineurin homologous protein as an essential cofactor for Na+/H+ exchangers. J Biol Chem;276:17367-17372.
106. Oxnard G.R., Arcila M.E., Chmielecki J., Ladanyi M., Miller V.A., Pao W. (2011) New strategies in overcoming acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer. Clin Cancer Res;17:5530-5537.
107. Grob T.J., Heilenkotter U., Geist S., Paluchowski P., Wilke C., Jaenicke F. et al. (2012) Rare oncogenic mutations of predictive markers for targeted therapy in triple-negative breast cancer. Breast Cancer Res Treat;134:561-567.
108. Scaltriti M., Rojo F., Ocana A., Anido J., Guzman M., Cortes J. et al. (2007) Expression of p95HER2, a truncated form of the HER2 receptor, and response to anti-HER2 therapies in breast cancer. J Natl Cancer Inst;99:628-638.
109. Garrett J.T., Arteaga C.L. (2011) Resistance to HER2-directed antibodies and tyrosine kinase inhibitors: mechanisms and clinical implications. Cancer Biol Ther;11:793-800.
110. Ayoola A., Barochia A., Belani K., Belani C.P. (2012) Primary and acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer: an update. Cancer Invest;30:433-446.
111. Gollob J.A., Wilhelm S., Carter C., Kelley S.L. (2006) Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway. Semin Oncol;33:392-406.
112. Davies H., Bignell G.R., Cox C., Stephens P., Edkins S., Clegg S. et al. (2002) Mutations of the BRAF gene in human cancer. Nature;417:949-954.
113. Cox A.D., Der C.J. (2010) Ras history: the saga continues. Small GTPases;1:2-27.
114. Wallert M., McCoy A., Voog J., Rastedt D., Taves-Patterson J., Korpi-Steiner N. et al. (2011) alpha-(1) adrenergic receptor-induced cytoskeletal organization and cell motility in CCL39 fibroblasts requires Phospholipase D1. J Cell Biochem;112:3025-3034.
115. Chiche J., Le Fur Y., Vilmen C., Frassineti F., Daniel L., Halestrap A.P. et al. (2012) In vivo pH in metabolic-defective Ras-transformed fibroblast tumors: key role of the monocarboxylate transporter, MCT4, for inducing an alkaline intracellular pH. Int J Cancer;130:1511-1520.
116. Nandan M.O., Yang V.W. (2011) An update on the biology of RAS/RAF mutations in colorectal cancer. Curr Colorectal Cancer Rep;7:113-120.
117. Bianchini L., L'Allemain G., Pouyssegur J. (1997) The p42/p44 mitogen-activated protein kinase cascade is determinant in mediating activation of the Na+/H+ exchanger (NHE1 isoform) in response to growth factors. J Biol Chem;272:271-279.
118. Kang M.G., Kulisz A., Wasserman W.J. (1998) Raf-1 kinase, a potential regulator of intracellular pH in Xenopus oocytes. Biol Cell;90:477-485.
119. Karki P., Li X., Schrama D., Fliegel L. (2011) B-Raf associates with and activates the NHE1 isoform of the Na+/H+ exchanger. J Biol Chem;286:13096-13105.
120. Poulikakos P.I., Solit D.B. (2011) Resistance to MEK inhibitors: should we co-target upstream? Sci Signal;4:pe16.
121. Kohno M., Tanimura S., Ozaki K. (2011) Targeting the extracellular signal-regulated kinase pathway in cancer therapy. Biol Pharm Bull;34:1781-1784.
122. Flaherty K.T., Hodi F.S., Bastian B.C. (2010) Mutation-driven drug development in melanoma. Curr Opin Oncol;22:178-183.
123. Villanueva J., Vultur A., Lee J.T., Somasundaram R., Fukunaga-Kalabis M., Cipolla A.K. et al. (2010) Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K. Cancer Cell;18:683-695.
124. Hatzivassiliou G., Liu B., O'Brien C., Spoerke J.M., Hoeflich K.P., Haverty P.M. et al. (2012) ERK inhibition overcomes acquired resistance to MEK inhibitors. Mol Cancer Ther;11:1143-1154.
125. Coccaro E., Karki P., Cojocaru C., Fliegel L. (2009) Phenylephrine and sustained acidosis activate the neonatal rat cardiomyocyte Na+/H+ exchanger through phosphorylation of amino acids Ser770 and Ser771. Am J Physiol Heart Circ Physiol;297:H846-H858.
126. Malo M.E., Li L., Fliegel L. (2007) Mitogen-activated protein kinase-dependent activation of the Na+/H+ exchanger is mediated through phosphorylation of amino acids Ser770 and Ser771. J Biol Chem;282:6292-6299.
127. Lin Y., Chang G., Wang J., Jin W., Wang L., Li H. et al. (2011) NHE1 mediates MDA-MB-231 cells invasion through the regulation of MT1-MMP. Exp Cell Res;317:2031-2040.
128. Jin W., Li Q., Lin Y., Lu Y., Li H., Wang L. et al. (2011) Reversal of Imatinib resistance in BCR-ABL-positive leukemia after inhibition of the Na+/H+ exchanger. Cancer Lett;308:81-90.
129. Pedersen S.F., Darborg B.V., Rentsch M.L., Rasmussen M. (2007) Regulation of mitogen-activated protein kinase pathways by the plasma membrane Na+/H+ exchanger, NHE1. Arch Biochem Biophys;462:195-201.
130. Romeo Y., Zhang X., Roux P.P. (2012) Regulation and function of the RSK family of protein kinases. Biochem J;441:553-569.
131. Takahashi E., Abe J., Gallis B., Aebersold R., Spring D.J., Krebs E.G. et al. (1999) p90(RSK) is a serum-stimulated Na+/H+ exchanger isoform-1 kinase. Regulatory phosphorylation of serine 703 of Na+/H+ exchanger isoform-1. J Biol Chem;274:20206-20214.
132. Lehoux S., Abe J., Florian J.A., Berk B.C. (2001) 14-3-3 Binding to Na+/H+ exchanger isoform-1 is associated with serum-dependent activation of Na+/H+ exchange. J Biol Chem;276:15794-15800.
133. Avkiran M., Cook A.R., Cuello F. (2008) Targeting Na+/H+ exchanger regulation for cardiac protection: a RSKy approach? Curr Opin Pharmacol;8:133-140.
134. Bril A., Avkiran M. (2008) Translating molecular target into drug therapy in cardiovascular disease. Curr Opin Pharmacol;8:111-113.
135. Karki P., Coccaro E., Fliegel L. (2010) Sustained intracellular acidosis activates the myocardial Na(+)/H(+) exchanger independent of amino acid Ser(703) and p90(rsk). Biochim Biophys Acta;1798:1565-1576.
136. Willems L., Tamburini J., Chapuis N., Lacombe C., Mayeux P., Bouscary D. (2012) PI3K and mTOR signaling pathways in cancer: new data on targeted therapies. Curr Oncol Rep;14:129-138.
137. Bartholomeusz C., Gonzalez-Angulo A.M. (2012) Targeting the PI3K signaling pathway in cancer therapy. Expert Opin Ther Targets;16:121-130.
138. Courtney K.D., Corcoran R.B., Engelman J.A. (2010) The PI3K pathway as drug target in human cancer. J Clin Oncol;28:1075-1083.
139. Aharonovitz O., Zaun H.C., Balla T., York J.D., Orlowski J., Grinstein S. (2000) Intracellular pH regulation by Na(+)/H(+) exchange requires phosphatidylinositol 4, 5-bisphosphate. J Cell Biol;150:213-224.
140. Abu Jawdeh B.G., Khan S., Deschenes I., Hoshi M., Goel M., Lock J.T. et al. (2011) Phosphoinositide binding differentially regulates NHE1 Na+/H+ exchanger-dependent proximal tubule cell survival. J Biol Chem;286:42435-42445.
141. Weiger M.C., Parent C.A. (2012) Phosphoinositides in chemotaxis. Subcell Biochem;59:217-254.
142. Gruver J.S., Wikswo J.P., Chung C.Y. (2008) 3′-phosphoinositides regulate the coordination of speed and accuracy during chemotaxis. Biophys J;95:4057-4067.
143. Funamoto S., Meili R., Lee S., Parry L., Firtel R.A. (2002) Spatial and temporal regulation of 3-phosphoinositides by PI 3-kinase and PTEN mediates chemotaxis. Cell;109:611-623.
144. Jenkins E.C. Jr, Debnath S., Gundry S., Uyar U., Fata J.E. (2012) Intracellular pH regulation by Na(+)/H(+) exchanger-1 (NHE1) is required for growth factor-induced mammary branching morphogenesis. Dev Biol;365:71-81.
145. Meima M.E., Webb B.A., Witkowska H.E., Barber D.L. (2009) The sodium-hydrogen exchanger NHE1 is an Akt substrate necessary for actin filament reorganization by growth factors. J Biol Chem;284:26666-26675.
146. Snabaitis A.K., Cuello F., Avkiran M. (2008) Protein kinase B/Akt phosphorylates and inhibits the cardiac Na+/H+ exchanger NHE1. Circ Res;103:881-890.
147. McCubrey J.A., Steelman L.S., Kempf C.R., Chappell W.H., Abrams S.L., Stivala F. et al. (2011) Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways. J Cell Physiol;226:2762-2781.
148. Steelman L.S., Navolanic P., Chappell W.H., Abrams S.L., Wong E.W., Martelli A.M. et al. (2011) Involvement of Akt and mTOR in chemotherapeutic- and hormonal-based drug resistance and response to radiation in breast cancer cells. Cell Cycle;10:3003-3015.
149. Sokolosky M.L., Stadelman K.M., Chappell W.H., Abrams S.L., Martelli A.M., Stivala F. et al. (2011) Involvement of Akt-1 and mTOR in sensitivity of breast cancer to targeted therapy. Oncotarget;2:538-550.
150. Yan W., Nehrke K., Choi J., Barber D.L. (2001) The Nck-interacting kinase (NIK) phosphorylates the Na+-H+ exchanger NHE1 and regulates NHE1 activation by platelet-derived growth factor. J Biol Chem;276:31349-31356.
151. Grenier A.L., Abu-ihweij K., Zhang G., Ruppert S.M., Boohaker R., Slepkov E.R. et al. (2008) Apoptosis-induced alkalinization by the Na+/H+ exchanger isoform 1 is mediated through phosphorylation of amino acids Ser726 and Ser729. Am J Physiol Cell Physiol;295:C883-C896.
152. Bertrand B., Wakabayashi S., Ikeda T., Pouyssegur J., Shigekawa M. (1994) The Na+/H+ exchanger isoform 1 (NHE1) is a novel member of the calmodulin-binding proteins. Identification and characterization of calmodulin-binding sites. J Biol Chem;269:13703-13709.
153. Fliegel L., Walsh M.P., Singh D., Wong C., Barr A. (1992) Phosphorylation of the C-terminal domain of the Na+/H+ exchanger by Ca2+/calmodulin-dependent protein kinase II. Biochem J;282(Pt 1):139-145.
154. Zaun H.C., Shrier A., Orlowski J. (2008) Calcineurin B homologous protein 3 promotes the biosynthetic maturation, cell surface stability, and optimal transport of the Na+/H+ exchanger NHE1 isoform. J Biol Chem;283:12456-12467.
155. Li X., Liu Y., Kay C.M., Muller-Esterl W., Fliegel L. (2003) The Na+/H+ exchanger cytoplasmic tail: structure, function, and interactions with tescalcin. Biochemistry;42:7448-7456.
156. Li X., Liu Y., Alvarez B.V., Casey J.R., Fliegel L. (2006) A novel carbonic anhydrase II binding site regulates NHE1 activity. Biochemistry;45:2414-2424.
157. Silva N.L., Haworth R.S., Singh D., Fliegel L. (1995) The carboxyl-terminal region of the Na+/H+ exchanger interacts with mammalian heat shock protein. Biochemistry;34:10412-10420.
158. Jung Y.S., Kim H.Y., Kim J., Lee M.G., Pouyssegur J., Kim E. (2008) Physical interactions and functional coupling between Daxx and sodium hydrogen exchanger 1 in ischemic cell death. J Biol Chem;283:1018-1025.
159. Xue J., Zhou D., Yao H., Gavrialov O., McConnell M.J., Gelb B.D. et al. (2007) Novel functional interaction between Na+/H+ exchanger 1 and tyrosine phosphatase SHP-2. Am J Physiol Regul Integr Comp Physiol;292:R2406-R2416.
160. Simonin A., Fuster D. (2010) Nedd4-1 and beta-arrestin-1 are key regulators of Na+/H+ exchanger 1 ubiquitylation, endocytosis, and function. J Biol Chem;285:38293-38303.
161. Wakabayashi S., Nakamura T.Y., Kobayashi S., Hisamitsu T. (2010) Novel phorbol ester-binding motif mediates hormonal activation of Na+/H+ exchanger. J Biol Chem;285:26652-26661.